Yseop’s AI-Powered augmented analyst chosen by Lilly to expedite the drug approval process and deploy automation at scale

News & Press Releases / By

The Unique Collaboration includes a Long-Term Commercial and Investment Agreement Between Yseop and Lilly, an Industry First for Natural Language Generation (NLG).

Yseop’s AI-Powered augmented analyst chosen by Lilly to expedite the drug approval process and deploy automation at scale Read More »